Improving the Utility of In Vitro Test Methods for Intranasal Drug Delivery
In this article, Dr Clair Brooks, Applications Specialist, and Matthew Fenn, Head of Business Development, discuss the development and validation of the Alberta Idealised Nasal Inlet (AINI), exploring how it can be used to optimise intranasal drug delivery and provide a realistic assessment of pulmonary deposition risk.
